Kantrowitz L B, Peterson M E, Trepanier L A, Melián C, Nichols R
Oradell Animal Hospital, NJ 07649, USA.
J Am Vet Med Assoc. 1999 Jun 15;214(12):1804-8.
To determine whether administration of phenobarbital, potassium bromide, or both drugs concurrently was associated with abnormalities in baseline serum total thyroxine (T4), triiodothyronine (T3), free T4, or thyrotropin (thyroid-stimulating hormone; TSH) concentrations in epileptic dogs.
Prospective case series.
78 dogs with seizure disorders that did not have any evidence of a thyroid disorder (55 treated with phenobarbital alone, 15 treated with phenobarbital and bromide, and 8 treated with bromide alone) and 150 clinically normal dogs that were not receiving any medication.
Serum total T4, total T3, free T4, and TSH concentrations, as well as serum concentrations of anticonvulsant drugs, were measured in the 78 dogs with seizure disorders. Reference ranges for hormone concentrations were established on the basis of results from the 150 clinically normal dogs.
Total and free T4 concentrations were significantly lower in dogs receiving phenobarbital (alone or with bromide), compared with concentrations in clinically normal dogs. Administration of bromide alone was not associated with low total or free T4 concentration. Total T3 and TSH concentrations did not differ among groups of dogs.
Results indicate that serum total and free T4 concentrations may be low (i.e., in the range typical for dogs with hypothyroidism) in dogs treated with phenobarbital. Serum total T3 and TSH concentrations were not changed significantly in association with phenobarbital administration. Bromide treatment was not associated with any significant change in these serum thyroid hormone concentrations.
确定给予苯巴比妥、溴化钾或同时给予这两种药物是否与癫痫犬的基线血清总甲状腺素(T4)、三碘甲状腺原氨酸(T3)、游离T4或促甲状腺激素(甲状腺刺激激素;TSH)浓度异常有关。
前瞻性病例系列研究。
78只患有癫痫疾病且无任何甲状腺疾病证据的犬(55只仅接受苯巴比妥治疗,15只接受苯巴比妥和溴化物治疗,8只仅接受溴化物治疗)以及150只未接受任何药物治疗的临床正常犬。
对78只患有癫痫疾病的犬测量血清总T4、总T3、游离T4和TSH浓度以及抗惊厥药物的血清浓度。根据150只临床正常犬的结果确定激素浓度的参考范围。
与临床正常犬的浓度相比,接受苯巴比妥(单独或与溴化物联合)治疗的犬的总T4和游离T4浓度显著降低。单独给予溴化物与总T4或游离T4浓度降低无关。各组犬的总T3和TSH浓度无差异。
结果表明,接受苯巴比妥治疗的犬的血清总T4和游离T4浓度可能较低(即处于甲状腺功能减退犬的典型范围内)。血清总T3和TSH浓度与苯巴比妥给药无显著变化。溴化物治疗与这些血清甲状腺激素浓度的任何显著变化无关。